PUFFMI's Strategy and Trends in Russia's E-Cigarette Market

Jun.17.2023
PUFFMI's Strategy and Trends in Russia's E-Cigarette Market
The PUFFMI brand showcased their large capacity, disposable e-cigarette products at the Russian trade show, catering to growing demand.

Special Statement:


This article is intended for internal industry research and communication purposes only and does not endorse any specific brand or product. Access is prohibited for minors.


At 12:00 Moscow time (17:00 Beijing time), the e-cigarette exhibition in Moscow, Russia's Crocus Expo exhibition center, opened. The event attracted numerous industry professionals, vendors, and consumers.


At the exhibition, 2FIRSTS conducted an exclusive interview with Songyu Yin, the regional sales representative of e-cigarette brand PUFFMI in Russia. He shared his insights on the Russian market and the brand strategy on behalf of the renowned e-cigarette brand PUFFMI.


The number of people expressing their opinions loudly is a trend.


At the exhibition, PUFFMI showcased their disposable e-cigarette products with a high mouth count, including options with 9,000 and 7,000 puffs.


Yin Songyu stated that these products have received very positive feedback. According to him, these products with oversized mouthpieces will hit the market in early July. Currently, PUFFMI has introduced disposable products with 4000 and 5000 mouthpieces in the Russian market, but still lacks products with even larger mouthpieces.


Yin Songyu pointed out that there is a growing demand among Russian consumers for large-sized disposable e-cigarette products. This trend seems to differ greatly from the mainstream e-cigarette consumer markets in Europe and the United States, where the focus is not on high numbers but on other factors.


The exhibit items showcased at the PUFFMI booth | Photo source: 2FIRSTS


Yin Songyu analyzed that first of all, in products with a small price gap, this type of product has a higher cost-effectiveness.


Furthermore, many consumers do not like to frequent physical stores for their purchases. They prefer to make a one-time purchase of a high-capacity e-cigarette.


This will be a trend in Russia.


Large numbers are still a trend.


Chasing the pod system.


In Russia, where disposable products are already the norm, major e-cigarette manufacturers are now focusing on developing pod systems. This shift is being driven by both economic and regulatory factors.


Yin Songyu candidly acknowledged that most mainstream Russian brands are pushing for the development of refillable products, as the tobacco stick itself is not subject to taxation. Compared to the e-liquid excise tax of 20 rubles per milliliter for disposable products, refillable products can achieve lower costs in the future. Additionally, given the increasingly stringent regulatory trend, this means that refillable products have greater potential in terms of market growth.


Tourists walk past the promotional image at the PUFFMI booth | Image source: 2FIRSTS


About 90% of the products on the market are considered to be in a gray zone.


He believes that a complete ban on flavored e-cigarettes is unlikely based on the series of regulations regarding e-cigarette passed by the National Duma. As for the list of additives and substances, he thinks that only the use of some harmful substances may be banned.


The new brand showcased at the PUFFMI booth | Image source: 2FIRSTS


The recent new policies have led to an increase in demand for Bai Guan products in the Russian market, and legalization of the market would be advantageous for the PUFFMI brand. Yin Songyu stated that the brand is anticipating the legalization of the market, as most of the current market is made up of illegal products.


Ninety percent of the products are mediocre.


He highlighted that the ratio between white tariffs and grey tariffs would be adjusted based on market demand.


It is worth mentioning that PUFFMI brand does not engage in online sales in the Russian market, but instead relies on offline sales channels.


Finally, Yin Songyu expressed confidence in PUFFMI's potential in the Russian market and has high hopes for the future development of the PUFFMI brand in Russia.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
AIR Global PLC (NASDAQ: AIIR) announced on November 5, 2026, that it had submitted a Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) for Crown Switch, its rechargeable pod vape platform. First launched in Germany in November 2025, the device uses Quantum Chip atomization technology developed by Canadian vaporization technology company Greentank Innovations. German retail versions feature 2mL prefilled pods containing 18mg/mL nicotine in six flavors, while AIR has separately tested two 5% nicotine formulations intended for U.S. development. AIR invested $20 million in Greentank in July and reported approximately $3.4 million in U.S. PMTA-related regulatory costs for the first nine months of 2026. The Crown Switch application has been submitted, but the FDA has not granted marketing authorization.
product
Nov.13
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
The European Patent Office (EPO) published an appeal decision on November 17, 2026, revoking Philip Morris Products S.A.'s European nicotine pouch patent EP 3773494, covering a formulation involving free-base nicotine, ion-exchange resin and a water content of at least 15%. The decision followed an opposition and appeal brought by British American Tobacco (BAT) entity Nicoventures Trading Limited. Philip Morris withdrew its approval of the patent text during the appeal, leading the EPO to revoke the patent. A separate European patent, EP 3809884, covering the distribution of nicotine between a pouch membrane and its internal composition, had been revoked on September 24 following a challenge from another BAT entity. The patents share a 2019 priority basis, while related European divisional applications also exist.
company
Nov.18 by 2Firsts Perspectives
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04